Study Protocol
Published on 15 May 2023
A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design
in Clinical Research in Nephrology
- 4,346 views
- 4 citations